T cell revival through PD-1: Clues for cancer immunotherapy

Scientists show which molecular features distinguish the subset of exhausted T cells that can be re-energized, when mice with chronic viral infections are treated with PD-1-blocking agents. Useful information for optimizing cancer immunotherapy and combinations with other drugs.